Mohamed ElRefai

Can we use deep-learning methods to guide patient selection for S-ICD therapy? Can artificial intelligence tools guide S-ICD programming to reduce oversensing and inappropriate shocks? Do we need to revisit S-ICD screening criteria? ⁦@JICE_EP⁩ link.springer.com/article/10.100…

@MoravskyOno @chesscom Rc1xd1

@chesscom How does black proceed after 1. Qxf1 Rc1 2. Rd1

Alireza plays a temporary queen sacrifice to end the game! 🔥 #TechMGCL #MegaMove

This year’s chemistry laureate Omar Yaghi was born in Amman, Jordan, in 1965 to parents who were refugees from Palestine. When we spoke to him he shared his story: “I grew up in a very humble home, we were a dozen of us in one room, sharing it with the cattle that we used to raise. I was born in a family of refugees, and my parents could barely read or write. My father finished sixth grade and my mother couldn’t read or write. It’s quite a journey. Science allows you to do it. Science is the greatest equalising force in the world. Smart people, talented people, skilled people exist everywhere. That’s why we really should focus on unleashing their potential through providing them with opportunity.” Today Yaghi shared the 2025 Nobel Prize in Chemistry with Susumu Kitagawa and Richard Robson for their work developing metal–organic frameworks. Learn more about the prize: nobelprize.org/prizes/chemist…

💡Where is the future of conduction system pacing heading? Dr Guram Imnadze reflects on its evolution and outlines what’s next in this expert-led tutorial from #EHRA2025 👉 ow.ly/jjmz50WA2iZ Gain personal insights on emerging techniques, current challenges and how #CSP is reshaping modern pacing strategies. 🎥 Watch now on demand [50 minutes]. #ConductionSystemPacing #CSP #CRM #Cardiology #EPeeps @GuramImnadze

@drjasondungu @MSEHospitals Well deserved

Received a Long Service Award from @MSEHospitals today, presented by Rob Brunger, Associate Director of HR. 10 years @ Basildon Hospital 😲 Proud of what I’ve achieved, especially delivering the Essex ICC service 🙌🏾 Worked with great people & honoured to serve our local patients

Iconic

“Always be kind around the hospitals. You’ll find people dealing with fear, grief, stress—rushing in with worry, waiting with hope, praying for news. Oh—and yes, there are also the patients”

SOUND ON. You’re hearing the first howl of a dire wolf in over 10,000 years. Meet Romulus and Remus—the world’s first de-extinct animals, born on October 1, 2024. The dire wolf has been extinct for over 10,000 years. These two wolves were brought back from extinction using genetic edits derived from a complete dire wolf genome, meticulously reconstructed by Colossal from ancient DNA found in fossils dating back 11,500 and 72,000 years. This moment marks not only a milestone for us as a company but also a leap forward for science, conservation, and humanity. From the beginning, our goal has been clear: “To revolutionize history and be the first company to use CRISPR technology successfully in the de-extinction of previously lost species.” By achieving this, we continue to push forward our broader mission on—accepting humanity’s duty to restore Earth to a healthier state. But this isn’t just our moment—it’s one for science, our planet, and humankind. All of which we love and are passionate about. Now, close your eyes and listen to that howl once more. Think about what this means for all of us.

📌 In👫anticipated to require frequent ventricular pacing 👉 Biventricular pacing is not superior to RV pacing #EPeeps #CardioTwitter #cardiacpacing #CRT @narrowQRS @SeguraCardio @KennethEllenbo1 @Hisdoc1 @drjohnm @JagSinghMD @DrJasonAndrade @drrakeshg1 @DhirajGuptaBHRS @EJSMD

Interesting. Is there a case to consider implanting pacemakers on the opposite side for patients who underwent previous LIMA grafting? 🧐

Scar burden, not the ejection fraction

@agadmator Does QB4 work as well?

Beautiful

Heart Failure with Preserved Ejection Fraction | New England Journal of Medicine #f1" target="_blank" rel="nofollow noopener">nejm.org/doi/full/10.10…

🎄🫖

Substitute one pillar for another? 🤔🧐 Finerenone: Will It Be a Game-changer? | CFR Journal cfrjournal.com/articles/finer…

And youngest ever

Happy to share our review on Device Therapy in Cardiac Sarcoidosis. Challenges and future prospectives @DrMenexi innovationsincrm.com/cardiac-rhythm…

SGLT2 inhibitors between the zeal of the clinical studies and the challenges of the day-to-day practice How 2 overcome inertia when it comes to #GDMT in #Heartfailure #dapagliflozin ⁦ ⁦@MAb_Card⁩ ⁦@pmhaydock⁩ ⁦@dralicezheng⁩ bjcardio.co.uk/2024/11/sglt2-…

Deep dive on #EARLYTAVR from ##TCT2024 Lots already said & discussed It takes time to read the paper, read the supplementary appendix, analyse the results, think about them etc! Some thoughts...🧵

Tomorrow - Oct 28th - we learn the results of 3 landmark randomised studies in patients with aortic stenosis (AS) Results of EARLY-TAVR, EVOLVED & TAVR UNLOAD will be unveiled at #TCT2024 in a Joint LBCT Session with #NEJM These could well be practice-changing studies... A 🧵

#25in25 #HeartFailure